Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Editorial of the Special Issue of MCAP: In Honour of Claude Lefèvre on Risk, Epidemics, Stochastic Orderings, Health and Economics.

Kryscio R, Loisel S, de Palma A, Patie P.

Methodol Comput Appl Probab. 2019 Jun;21(2):387-389. doi: 10.1007/s11009-019-09705-9. Epub 2019 Mar 22. No abstract available.

PMID:
31768126
2.

Sexual isolation with and without ecological isolation in marine isopods Jaera albifrons and J. praehirsuta.

Ribardière A, Pabion E, Coudret J, Daguin-Thiébaut C, Houbin C, Loisel S, Henry S, Broquet T.

J Evol Biol. 2019 Oct 21. doi: 10.1111/jeb.13559. [Epub ahead of print]

PMID:
31631475
3.

Brief Report: Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence.

Loisel S, Dulong J, Ménard C, Renoud ML, Meziere N, Isabelle B, Latour M, Bescher N, Pedeux R, Bertheuil N, Flecher E, Sensebé L, Tarte K.

Stem Cells. 2017 May;35(5):1431-1436. doi: 10.1002/stem.2580. Epub 2017 Feb 23.

4.

Understanding leachate flow in municipal solid waste landfills by combining time-lapse ERT and subsurface flow modelling - Part I: Analysis of infiltration shape on two different waste deposit cells.

Audebert M, Clément R, Moreau S, Duquennoi C, Loisel S, Touze-Foltz N.

Waste Manag. 2016 Sep;55:165-75. doi: 10.1016/j.wasman.2016.04.006. Epub 2016 Apr 18.

PMID:
27103399
5.

Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions.

Cretenet G, Clerc I, Matias M, Loisel S, Craveiro M, Oburoglu L, Kinet S, Mongellaz C, Dardalhon V, Taylor N.

Sci Rep. 2016 Apr 12;6:24129. doi: 10.1038/srep24129.

6.

Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.

Golay J, Choblet S, Iwaszkiewicz J, Cérutti P, Ozil A, Loisel S, Pugnière M, Ubiali G, Zoete V, Michielin O, Berthou C, Kadouche J, Mach JP, Duonor-Cérutti M.

J Immunol. 2016 Apr 1;196(7):3199-211. doi: 10.4049/jimmunol.1501592. Epub 2016 Feb 26.

7.

Hypoxia Differentially Modulates the Genomic Stability of Clinical-Grade ADSCs and BM-MSCs in Long-Term Culture.

Bigot N, Mouche A, Preti M, Loisel S, Renoud ML, Le Guével R, Sensebé L, Tarte K, Pedeux R.

Stem Cells. 2015 Dec;33(12):3608-20. doi: 10.1002/stem.2195. Epub 2015 Oct 8.

8.

Index for Predicting Insurance Claims from Wind Storms with an Application in France.

Mornet A, Opitz T, Luzi M, Loisel S.

Risk Anal. 2015 Nov;35(11):2029-56. doi: 10.1111/risa.12395. Epub 2015 May 5.

PMID:
25943432
9.

ING1b negatively regulates HIF1α protein levels in adipose-derived stromal cells by a SUMOylation-dependent mechanism.

Bigot N, Guérillon C, Loisel S, Bertheuil N, Sensebé L, Tarte K, Pedeux R.

Cell Death Dis. 2015 Jan 22;6:e1612. doi: 10.1038/cddis.2014.577.

10.

Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.

Vincent M, Teppaz G, Lajoie L, Solé V, Bessard A, Maillasson M, Loisel S, Béchard D, Clémenceau B, Thibault G, Garrigue-Antar L, Jacques Y, Quéméner A.

MAbs. 2014 Jul-Aug;6(4):1026-37.

11.

Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.

Loisel S, André PA, Golay J, Buchegger F, Kadouche J, Cérutti M, Bologna L, Kosinski M, Viertl D, Delaloye AB, Berthou C, Mach JP, Boumsell L.

Mol Cancer. 2011 Apr 19;10:42. doi: 10.1186/1476-4598-10-42.

12.

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia.

Loisel S, Le Ster K, Meyer M, Berthou C, Youinou P, Kolb JP, Billard C.

J Hematol Oncol. 2010 Dec 7;3:49. doi: 10.1186/1756-8722-3-49.

13.

A case for the graft-versus-host disease as a model for B cell-mediated autoimmunity.

Segalen I, Fali T, Pers JO, Le Meur Y, Youinou P, Loisel S.

Autoimmun Rev. 2011 Feb;10(4):218-21. doi: 10.1016/j.autrev.2010.10.005. Epub 2010 Oct 16. Review.

PMID:
20955823
14.

Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome.

Alonso R, Buors C, Le Dantec C, Hillion S, Pers JO, Saraux A, Montero E, Marianowski R, Loisel S, Devauchelle V, Youinou P, Renaudineau Y.

J Autoimmun. 2010 Dec;35(4):336-41. doi: 10.1016/j.jaut.2010.07.005.

PMID:
20810246
15.

Updating the physiology, exploration and disease relevance of complement factor H.

Buhé V, Loisel S, Pers JO, Le Ster K, Berthou C, Youinou P.

Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):397-404. Review.

PMID:
20646335
16.

Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Alonso-Ramirez R, Loisel S, Buors C, Pers JO, Montero E, Youinou P, Renaudineau Y.

Arthritis. 2010;2010:130646. doi: 10.1155/2010/130646. Epub 2011 Feb 10.

17.

CpG ODN enhances the efficacy of rituximab in non-Hodgkin lymphoma.

Buhé V, Guerrier T, Youinou P, Berthou C, Loisel S.

Ann N Y Acad Sci. 2009 Sep;1173:858-64. doi: 10.1111/j.1749-6632.2009.04615.x.

PMID:
19758238
18.

Development of a Murine model to dissect the CpG-oligonucleotide-enhancement of the killing of human B Cells by rituximab.

Buhé V, Pers JO, Marianowski R, Berthou C, Youinou P, Loisel S.

J Autoimmun. 2010 Mar;34(2):136-44. doi: 10.1016/j.jaut.2009.08.007. Epub 2009 Sep 1.

PMID:
19726161
19.

Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?

Mankaï A, Eveillard JR, Buhé V, Le Ster K, Loisel S, Ghedira I, Youinou P, Berthou C, Bordron A.

Ann N Y Acad Sci. 2007 Jun;1107:193-205.

PMID:
17804547
21.

BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.

Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, Hutin P, Renaudineau Y, Dueymes M, Loisel S, Berthou C, Saraux A, Youinou P.

Arthritis Rheum. 2007 May;56(5):1464-77.

22.

Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.

Loisel S, Ohresser M, Pallardy M, Daydé D, Berthou C, Cartron G, Watier H.

Crit Rev Oncol Hematol. 2007 Apr;62(1):34-42. Epub 2007 Jan 2. Review.

PMID:
17197192
23.

Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice model.

Mineo JF, Bordron A, Quintin-Roué I, Maurage CA, Buhé V, Loisel S, Dubois F, Blond S, Berthou C.

J Neurooncol. 2006 Feb;76(3):249-55. Erratum in: J Neurooncol. 2007 Sep;84(3):331. Isabelle, Quintin-Roué [corrected to Quintin-Roué, Isabelle]; Virginie, Buhé [corrected to Buhé, Virginie]; Séverine, Loisel [corrected to Loisel, Séverine].

PMID:
16200345
24.

Establishment of a novel human B-CLL-like xenograft model in nude mouse.

Loisel S, Ster KL, Quintin-Roue I, Pers JO, Bordron A, Youinou P, Berthou C.

Leuk Res. 2005 Nov;29(11):1347-52.

PMID:
15896841
25.

Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas.

Mineo JF, Bordron A, Quintin-Roué I, Loisel S, Ster KL, Buhé V, Lagarde N, Berthou C.

Br J Cancer. 2004 Sep 13;91(6):1195-9.

26.

Specific signaling pathways triggered by IL-2 in human V gamma 9V delta 2 T cells: an amalgamation of NK and alpha beta T cell signaling.

Lafont V, Loisel S, Liautard J, Dudal S, Sablé-Teychené M, Liautard JP, Favero J.

J Immunol. 2003 Nov 15;171(10):5225-32.

27.

Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes.

Loisel S, Le Gall C, Doucet L, Ferec C, Floch V.

Hum Gene Ther. 2001 Apr 10;12(6):685-96.

PMID:
11426467
28.

Factors influencing the efficiency of lipoplexes mediated gene transfer in lung after intravenous administration 1 *.

Loisel S, Floch V, Le Gall C, Férec C.

J Liposome Res. 2001;11(2-3):127-38. doi: 10.1081/LPR-100108457.

PMID:
19530928
29.

Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity.

Floch V, Loisel S, Guenin E, Hervé AC, Clement JC, Yaouanc JJ, des Abbayes H, Férec C.

J Med Chem. 2000 Nov 30;43(24):4617-28.

PMID:
11101353
30.

Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications.

Delépine P, Guillaume C, Floch V, Loisel S, Yaouanc J, Clément J, Des Abbayes H, Férec C.

J Pharm Sci. 2000 May;89(5):629-38.

PMID:
10756328
31.

Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency.

Floch V, Delépine P, Guillaume C, Loisel S, Chassé S, Le Bolc'h G, Gobin E, Leroy JP, Férec C.

Biochim Biophys Acta. 2000 Mar 15;1464(1):95-103.

32.

Cationic Phosphonolipids Containing Quaternary Phosphonium and Arsonium Groups for DNA Transfection with Good Efficiency and Low Cellular Toxicity**

Guénin E, Hervé AC, Floch V V, Loisel S, Yaouanc JJ, Clément JC, Férec C, des Abbayes H.

Angew Chem Int Ed Engl. 2000 Feb;39(3):629-631.

PMID:
10671280
33.

New biocompatible cationic amphiphiles derivative from glycine betaine: a novel family of efficient nonviral gene transfer agents.

Floch V, Legros N, Loisel S, Guillaume C, Guilbot J, Benvegnu T, Ferrieres V, Plusquellec D, Ferec C.

Biochem Biophys Res Commun. 1998 Oct 9;251(1):360-5.

PMID:
9790961

Supplemental Content

Loading ...
Support Center